key: cord-0735494-gicl8q9v authors: Das, Jayanta Kumar; Chakraborty, Subhadip; Roy, Swarup title: A Scheme for Inferring Viral-Host Associations based on Codon Usage Patterns Identifies the Most Affected Signaling Pathways during COVID-19 date: 2021-05-07 journal: J Biomed Inform DOI: 10.1016/j.jbi.2021.103801 sha: 1e81feccd5c8012a57243275f66750987b231b66 doc_id: 735494 cord_uid: gicl8q9v Understanding the molecular mechanism of COVID-19 disease pathogenesis helps in the rapid development of therapeutic targets. Usually, viral protein targets host proteins in an organized fashion. The expression of any viral gene depends mostly on the host translational machinery. Recent studies report the great significance of codon usage biases in establishing host-viral protein-protein interactions (PPI). Exploring the codon usage patterns between a pair of co-evolved host and viral proteins may present novel insight into the host-viral protein interactomes during disease pathogenesis. Leveraging the similarity (and dissimilarity) in codon usage patterns, we propose a computational scheme to recreate the host-viral protein-protein interaction network. We use host proteins from seventeen (17) essential signaling pathways for our current work towards understanding the possible targeting mechanism of SARS-CoV-2 viral proteins. We infer both negatively and positively interacting edges in the network. Further, extensive analysis is performed to understand the host PPI network topologically and the attacking behavior of the viral proteins. Our study reveals that viral proteins mostly utilize codons, rare in the targeted host proteins (negatively correlated interaction). Among non-structural proteins, NSP3 and structural protein, Spike (S) protein, are the most influential proteins in interacting multiple host proteins. While ranking the most affected pathways, MAPK pathways observe to be the worst affected during the COVID-19 disease. Several proteins participating in multiple pathways are highly central in host PPI and mostly targeted by multiple viral proteins. We observe many potential targets (host proteins) from the affected pathways associated with the various drugs molecules including Arsenic trioxide, Dexamethasone, Hydroxychloroquine, Ritonavir, and Interferon beta, which are either under trail or in use during COVID-19. The entire world is passing through an unprecedented pandemic situation due to a mas-2 sive outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 ) infected 3 viral disease, COVID-19. SARS-CoV-2 belongs to the Coronaviridae family, and members of 4 this family are enveloped, non-segmented, single-stranded, positive-sense large RNA genomes 5 [1] . This virus rapidly spreads from person to person by respiratory droplets during close 6 physical contact. Other than respiratory organs, it is reported to attack the immune system, 7 and other vital cellular machinery leads to multi-organ failure [2] . The need for the hour and 8 utmost crucial for the scientific community to understand the disease pathogenesis of CoV-2 at genomic and proteomic levels for the rapid development of effective drugs or vaccines 10 to control the COVID-19. Many recent works use host-viral protein-protein interaction net- 11 work as an input to elucidate potential drug targets or repurposed drug molecules [3, 4, 5]. 12 Host-pathogen protein interactions provide essential insights into the molecular mechanisms of 13 pathogenecity [6]. 14 The host defense mechanism activates signal transduction molecules that initiate signals, 15 which activate immune effector mechanisms to protect the host from any pathogenic infections. 16 Studies show that viral immune modulators perturb the human PPI network by targeting viral pathogenesis, and cell transformation [9] . We aim to study the interaction pattern of 28 SARS-CoV-2 with its target host proteins involved in signaling pathways [10, 11, 12, 13, 14, 15] 29 (see Materials and Method section). Working with them can help in deciphering the possible 30 involvement of pathways and key genes during COVID-19 pathogenesis. The virus-host interactome is essential for understanding virulence factors, influencing 32 SARS-CoV-2 pathogenesis [16] . Recent studies reported the use of SARS-CoV-2 and host PPI 33 networks to study the pathogenesis of SARS-CoV-2 and identify repurposed drugs [17, 4, 18] . 34 Several studies have shown that viral proteins interact with hubs in complex host PPI net-35 work [19, 20] . Considering different properties of proteins such as sequence homology, gene co-36 expression, and phylogenetic profiles [21, 22, 23] , the pairwise similarity is computed between 37 a pair of proteins to predict a possible interaction between them. In addition to non-structural 38 information, structural data about a pair of proteins appears to be more effective in improving Th17 cell differentiationl 108 Cytokine-cytokine receptor interaction 295 TGF-beta signaling pathway 95 TNF signaling pathway 113 Toll-like receptor signaling pathway 105 IL-17 signaling pathway 95 HIF-1 signaling pathway 110 RIG-I-like receptor signaling pathway 70 Apoptosis 137 MAPK signaling pathway 295 Insulin signaling pathway 138 Chemokine signaling pathway 190 mTOR signaling pathway where, X i,j is the number of occurrences of the j th codon for the i th amino acid, which is 112 encoded by n i synonymous codons. The RSCU score of a codon more than 1.0 indicates excess 113 usage (biased) of the codon, and less than 1.0 marks low usage of that particular codon. 114 We generate a 59-dimensional RSCU feature vector for each coding protein. where, x i ∈ R v and y i ∈ R h ,R v andR h are the mean of the vectors R v and R h respectively. To determine significantly correlated pair of RSCU vectors, we use 2-tailed p measure- i.e. p(R v , R h ) < τ . We use SciPy version 1.5.0 (sipy.stats) 3 for calculating ρ and p value. Given a set of viral proteins, V = {v 1 , v 2 , · · · v n } and host proteins H = {h 1 , h 2 , · · · h n } we 143 can create a bipartite graph in the form of adjacency matrix using above ρ and p measures as 144 follows. 145 3 https://scipy.org Next, we investigate the interaction mechanism of SARS-CoV-2 proteins with the proteins involved in certain signaling pathways as discussed (Table 2) . . We apply our method to these three networks, and we 159 observe approximately 54% interactions (average) for the above three networks ( in Table 3 . For more detail results one can refer to Supplementary-c. We report codon usage distribution of 59 codons across 26 viral proteins (SARS-CoV-2) 169 and 1313 host proteins in Figure 2 star-like topology only and unable to report any host protein oriented multiple interactions. 193 We report a list of such highly connected host proteins with the viral proteins (total of 15) in 194 Table 4 . Many (viral) to one (host) interactions are also reported (Supplementary-D). 195 its importance in its network, i.e., host-host protein networks. If a host protein is significant 227 concerning its degree, suitable repurposed drug molecules may be identified for the same. While focusing on highly interacting viral proteins, interestingly, we observe that the max- of structural proteins, S is a highly interacting (more than 600) protein. Out of accessory 231 proteins, Orf8 shows a maximum interaction count next to protein S. 232 We report the degree distribution for each of the viral proteins from our network in Figure 5 We show the degree distribution of 859 host proteins in Figure 5 To study the most affected pathways in our 17 candidate set of pathways, we rank them 251 based on the percentage of host proteins targeted by any viral proteins out of total proteins 252 involved in those pathways, and report in Figure 6 . The topmost pathway is Mitogen-Activated Protein Kinase (MAPK) signaling pathway. More than 50% proteins from this pathway are targeted by different SARS-CoV-2 proteins. proteins 5 . We report the top 100 central proteins in the Supplementary-A (Table S2 ). We (Table S2) . Interestingly, in terms of the number of targeted proteins, which are also central 308 in host-host PPI, the signaling pathway MAPK is one of the worst affected pathways among 17 309 candidate pathways. In addition to PPI centrality, we study the pathway centrality of the host Table S3 ). We ranked those drugs based on their 323 counts of protein targets in our network (Table 6) of such drugs are given in Supplementary-A (Table S3 ). It can be observed from the Table 6 326 that a single drug is having targets in multiple pathways forming a bipartite graph as shown 327 in Figure 8 . 328 We discuss below the drugs that are associated with COVID-19 disease and having potential 329 target host proteins involved in our inferred host-viral networks. which is thought to dysregulate in COVID-19 . 364 We believe that a pathway that is mostly targeted by different SARS-CoV-2 proteins and Interferon beta 5 4 0 9 Ritonavir 15 3 0 10 Our method is generic and useful to draw a more extensive network, covering genes from map reveals targets for drug repurposing, Nature (2020) 1-13. Cryo-em structure of the 2019-ncov spike in the prefusion con-395 formation Effect of covid-19 on the organs Th17 responses in cytokine storm of covid-19: An emerging target 420 of jak2 inhibitor fedratinib mtor signalling pathway-a root cause for idiopathic autism? Targeting jak-stat signaling to 426 control cytokine release syndrome in covid-19 Inflammatory cytokine: Il-17a signaling pathway in patients present with 428 covid-19 and current treatment strategy p38 mapk inhibition: A promising therapeutic approach for 430 covid-19 Virus-host interactome and proteomic survey of pbmcs from covid-19 patients 433 reveal potential virulence factors influencing sars-cov-2 pathogenesis Covid-19: viral-host interactome analyzed 437 by network based-approach model to study pathogenesis of sars-cov-2 infection Data science in unveiling 440 covid-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing When the human viral infectome 443 and diseasome networks collide: towards a systems biology platform for the aetiology of 444 human diseases The landscape of human proteins interacting with 446 viruses and other pathogens Geometric de-noising of protein-448 protein interaction networks Homology-based prediction of interactions between proteins 450 using averaged one-dependence estimators Computational methods of analysis of protein-protein inter-452 actions Codon usage similarity between viral and some host 489 genes suggests a codon-specific translational regulation Comprehensive analysis of correlations among 491 codon usage bias, gene expression, and substitution rate in arachis duranensis and arachis 492 ipaënsis orthologs Unexpected correlations between gene expression 494 and codon usage bias from microarray data for the whole escherichia coli k-12 genome Roles for synonymous codon usage in protein biogenesis Can simple codon pair usage predict 499 protein-protein interaction? Protein-protein interactions: detection, 501 reliability assessment and applications Protein-protein interaction detection: meth-503 ods and analysis Codon catalog usage and the 505 genome hypothesis The charac-507 teristics of the synonymous codon usage in enterovirus 71 virus and the effects of host on 508 the virus in codon usage pattern Tissue-specific codon usage and the expression of 510 human genes Reduction of the rate of 512 poliovirus protein synthesis through large-scale codon deoptimization causes attenuation 513 of viral virulence by lowering specific infectivity Immune evasion in human papillomavirus-associated cervical cancer A new coronavirus associated with human respiratory disease in china A study on non-synonymous mutational patterns in structural proteins 520 of sars-cov-2 Sars-cov-2 proteins exploit host's genetic The pearson product-moment correlation coefficient 554 is better suited for identification of dna fingerprint profiles than band matching algorithms Pearson correlation coefficient, in: Noise 557 reduction in speech processing Pearson's correlation coefficient Multi-level proteomics reveals host-perturbation 561 strategies of sars-cov-2 and sars-cov Biogrid: a 563 general repository for interaction datasets Virusmint: a viral protein interaction database Analysis of synonymous codon usage in sars 568 coronavirus and other viruses in the nidovirales Analysis of pre-570 ferred codon usage in the coronavirus n genes and their implications for genome evolution 571 and vaccine design An omnibus test of normality for moderate and large size samples Tests for departure from normality. empirical results 575 for the distributions of b 2 and b Statistical mechanics of complex networks Blood single cell immune profiling reveals the interferon-mapk pathway mediated 580 adaptive immune response for covid-19 Sars coronavirus papain-like protease induces egr-1-dependent up-regulation of tgf-β1 via 583 ros/p38 mapk/stat3 pathway Error and attack tolerance of complex networks Molecular principles of human virus protein-protein 587 interactions Acute leukemia in the time of covid-19 Impact of covid-19 on the 591 treatment of acute myeloid leukemia Dexamethasone 594 nanomedicines for covid-19 Dexamethasone for covid-19? not so fast Efficacy 598 of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial Hydroxychloroquine 602 in nonhospitalized adults with early covid-19: a randomized trial Transcriptional control of the tnf gene A trial of lopinavir-ritonavir in covid-19 Clinical efficacy of lopinavir/ritonavir in the treatment of coronavirus disease